Plasma selenium is positively related to performance in neurological tasks assessing coordination and motor speed.

Laboratory of Epidemiology, Demography and Biometry, National Institue on Aging, Bethesda, Maryland, USA.
Movement Disorders (Impact Factor: 5.63). 09/2010; 25(12):1909-15. DOI: 10.1002/mds.23218
Source: PubMed

ABSTRACT Parkinson's disease (PD) is a degenerative process affecting the striato nigral system (SN). Its etiology, although obscure, may involve oxidative damage. Selenium, an antioxidant, was shown to protect the SN in animal models. In the current study, we investigate the association between plasma selenium concentrations and the presence of "soft" neurological signs related to the SN. Plasma selenium concentration was assessed in participants of age ≥65 years in the InCHIANTI study, a population-based cohort study in Tuscany, Italy. PD was defined based on standard criteria. "Soft" neurological signs were ascertained by physical examination. A total of 1,012 participants were included. No association was found between the presence of PD and plasma selenium. There was, however, a strong association between plasma selenium and timed performance-based assessments. Lower levels of selenium were significantly associated withdecreased performance in neurological tests of coordination among older adults. Prospective studies are needed to further investigate the effects of selenium on SN dysfunction.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The aims of this study were to evaluate and contrast the physical attributes that are associated with self-reported vs. observed ability to walk 400 m among older adults. Analysis of baseline and 3-yr data from 1026 participants 65 yrs or older in the InCHIANTI (Invecchiare in Chianti) study was conducted. Observed and self-reported ability to walk 400 m at baseline and at 3 yrs were primary outcomes. Predictors included leg speed, leg strength, leg strength symmetry, range of motion, balance, and kyphosis. Balance, leg speed, leg strength, kyphosis, leg strength symmetry, and knee range of motion were associated with self-reported ability to walk 400 m at baseline (P < 0.001, c = 0.85). Balance, leg speed, and knee range of motion were associated with observed 400-m walk (P < 0.001, c = 0.85) at baseline. Prospectively, baseline leg speed and leg strength were predictive of both self-reported (P < 0.001, c = 0.79) and observed (P < 0.001, c = 0.72) ability to walk 400 m at 3 yrs. The profiles of attributes that are associated with self-reported vs. observed walking ability differ. The factor most consistently associated with current and future walking ability is leg speed. These results draw attention to important foci for rehabilitation.
    American journal of physical medicine & rehabilitation / Association of Academic Physiatrists 12/2013; · 1.56 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The essential trace element selenium, as selenocysteine, is incorporated into antioxidant selenoproteins such as glutathione peroxidases (GPx), thioredoxin reductases (TrxR) and selenoprotein P (Sepp1). Although comparatively low in selenium content, the brain exhibits high priority for selenium supply and retention under conditions of dietary selenium deficiency. Liver-derived Sepp1 is the major transport protein in plasma to supply the brain with selenium, serving as a "survival factor" for neurons in culture. Sepp1 expression has also been detected within the brain. Presumably, astrocytes secrete Sepp1, which is subsequently taken up by neurons via the apolipoprotein E receptor 2 (ApoER2). Knock-out of Sepp1 or ApoER2 as well as neuron-specific ablation of selenoprotein biosynthesis results in neurological dysfunction in mice. Astrocytes, generally less vulnerable to oxidative stress than neurons, are capable of up-regulating the expression of antioxidant selenoproteins upon brain injury. Occurrence of neurological disorders has been reported occasionally in patients with inadequate nutritional selenium supply or a mutation in the gene encoding selenocysteine synthase, one of the enzymes involved in selenoprotein biosynthesis. In three large trials carried out among elderly persons, a low selenium status was associated with faster decline in cognitive functions and poor performance in tests assessing coordination and motor speed. Future research is required to better understand the role of selenium and selenoproteins in brain diseases including hepatic encephalopathy.
    Archives of Biochemistry and Biophysics 03/2013; · 3.37 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To identify the neuromuscular attributes that are associated with self reported mobility status among older primary care patients DESIGN: Cohort Study SETTING: Metropolitan based health care system PARTICIPANTS: Community-dwelling primary care patients age ≥ 65 years (N=430), with self-reported modification of mobility tasks resulting from underlying health conditions. Basic and Advanced Lower Extremity Function as measured by the Late Life Function and Disability Instrument RESULTS: We constructed multivariable linear regression models evaluating both outcomes. For Basic- Lower Extremity Function, leg strength, leg velocity, trunk extensor muscle endurance and ankle range of motion were statistically significant predictors (p<.001 R2 = .21). For Advanced-Lower Extremity Function, leg strength, leg strength asymmetry, leg velocity, trunk extensor muscle endurance and knee flexion range of motion were statistically significant predictors (p<.001, R2 =.39). Sensitivity analyses conducted using multiple imputations to account for missing data confirmed these findings. This analysis highlights the relevance and importance of 5 categories of neuromuscular attributes: strength, speed of movement, range of motion, asymmetry and trunk stability. It identifies novel attributes (leg velocity and trunk extensor muscle endurance) relevant to mobility and highlights that impairment profiles vary by the level of mobility assessed. These findings will inform the design of more thorough and potentially more effective disability prevention strategies.
    Archives of physical medicine and rehabilitation 08/2013; · 2.18 Impact Factor

Full-text (2 Sources)

Available from
May 27, 2014